These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9928391)

  • 1. Effects of the anti-CD2 mAb OX34 on in vivo proliferation.
    Hoffmann JC; Herklotz C; Zeitz M; Bayer B; Zeidler H; Westermann J
    Ann N Y Acad Sci; 1998 Nov; 859():216-8. PubMed ID: 9928391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down-modulation.
    Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Westermann J
    Clin Exp Immunol; 1997 Oct; 110(1):63-71. PubMed ID: 9353150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2.
    Hirahara H; Tsuchida M; Watanabe T; Haga M; Matsumoto Y; Abo T; Eguchi S
    Transplantation; 1995 Jan; 59(1):85-90. PubMed ID: 7839434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
    Stell D; Marshall H; Bradley JA; Bolton EM
    Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.
    Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Rosenthal H; Westermann J
    Ann Rheum Dis; 1997 Dec; 56(12):716-22. PubMed ID: 9496150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance.
    Krieger NR; Most D; Bromberg JS; Holm B; Huie P; Sibley RK; Dafoe DC; Alfrey EJ
    Transplantation; 1996 Nov; 62(9):1285-92. PubMed ID: 8932273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production.
    Sido B; Dengler TJ; Otto G; Zimmermann R; Müller P; Meuer SC
    Eur J Immunol; 1998 Apr; 28(4):1347-57. PubMed ID: 9565375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis.
    Inomata T; Watanabe T; Haga M; Hirahara H; Abo T; Okura Y; Hanawa H; Kodama M; Izumi T
    Jpn Heart J; 2000 Jul; 41(4):507-17. PubMed ID: 11041101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat.
    Barlow AK; Like AA
    Am J Pathol; 1992 Nov; 141(5):1043-51. PubMed ID: 1359788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction.
    Horwitz DA; Tang FL; Stimmler MM; Oki A; Gray JD
    Arthritis Rheum; 1997 May; 40(5):822-33. PubMed ID: 9153542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better-surviving liver grafts by the injection of anti-CD2 antibody: the important roles of host CD8+ and CD2+CD28+ T cells in chronic graft rejection and beta type platelet-derived growth factor receptor (PDGFR-beta) expression on apoptotic liver grafts.
    Nakatsuji T
    Tohoku J Exp Med; 1999 Mar; 187(3):215-25. PubMed ID: 10458478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective deletion of antigen-specific, activated T cells by a humanized MAB to CD2 (MEDI-507) is mediated by NK cells.
    Branco L; Barren P; Mao SY; Pfarr D; Kaplan R; Postema C; Langermann S; Koenig S; Johnson S
    Transplantation; 1999 Nov; 68(10):1588-96. PubMed ID: 10589960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.
    Jung S; Toyka K; Hartung HP
    Brain; 1996 Aug; 119 ( Pt 4)():1079-90. PubMed ID: 8813272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and preferential expansion of rat cytotoxic (CD8) T cells in vitro and in vivo with a bispecific (anti-TCR alpha/beta x anti-CD2) F(ab')2 antibody.
    Tutt AL; Reid R; Wilkins BS; Glennie MJ
    J Immunol; 1995 Sep; 155(6):2960-71. PubMed ID: 7673714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients.
    Saoudi A; Castedo M; Nochy D; Mandet C; Pasquier R; Druet P; Pelletier L
    Eur J Immunol; 1995 Jul; 25(7):1972-9. PubMed ID: 7621873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322.
    Nizet Y; Chentoufi AA; de la Parra B; Lewalle P; Rouas R; Cornet A; Besse T; Mourad M; Malaise J; Squifflet JP; Bazin H; Latinne D
    Transplantation; 2000 Apr; 69(7):1420-8. PubMed ID: 10798765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.